Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2000, p. 1936-1942, Vol. 44, No. 7
Laboratoire de Bactériologie,
Faculté de Médecine, 63001 Clermont-Ferrand
Cedex,1 and UMR 175, CNRS-MNHN,
29000 Quimper,3 France, and Setor de
Bacteriologia, Laboratório Lâmina LTDA, 71 Botafogo,
Rio de Janeiro, Brazil 22280-0302
Received 18 October 1999/Returned for modification 25 March
2000/Accepted 12 April 2000
To estimate the diversity of extended-spectrum
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Novel CTX-M
-Lactamase (CTX-M-8) in Cefotaxime-Resistant
Enterobacteriaceae Isolated in Brazil
-lactamases in
Brazil, 18 strains from different species of the family
Enterobacteriaceae exhibiting a positive double-disk
synergy test were collected by a clinical laboratory from several
hospitals in Rio de Janeiro, Brazil, in 1996 and 1997. Four strains
(Proteus mirabilis, Enterobacter cloacae,
Enterobacter aerogenes, and Citrobacter
amalonaticus) hybridized with a 550-bp CTX-M probe. The P. mirabilis strain produced a CTX-M-2 enzyme. The E. cloacae, E. aerogenes, and C. amalonaticus isolates harbored a bla gene which was
identified by cloning and sequencing as a
blaCTX-M gene. E. coli HB101
transconjugants and the E. coli DH5
transformant
harboring a recombinant plasmid produced a CTX-M
-lactamase with an
isoelectric point of 7.6 conferring a resistance phenotype
characterized by a higher level of resistance to cefotaxime than to
ceftazidime, as observed with the other CTX-M enzymes. The deduced
protein sequence showed a novel Ambler class A CTX-M enzyme, named
CTX-M-8, which had 83 to 88% identity with the previously described
CTX-M enzymes. The phylogenic study of the CTX-M family including
CTX-M-8 revealed four CTX-M types, CTX-M-8 being the first member of a
new phylum of CTX-M enzymes. The evolutionary distances between the
four types of CTX-M were large, suggesting that the four clusters
branched off early from a distant unknown enzyme and that intermediate enzymes probably existed.
*
Corresponding author. Mailing address: Faculté de
Médicine, Service de Bactériologie-Virologie, 28, Place
Henri Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 (0) 4 73 60 80 18. Fax: 33 (0) 4 73 27 74 94. E-mail:
Richard.Bonnet{at}u-clermont1.fr.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |